Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/146719
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Small GSK-3 inhibitor shows efficacy in a motor neuron disease murine model modulating autophagy |
Autor: | De Munck, E.; Palomo, Valle CSIC ORCID ; Muñoz-Sáez, E.; Pérez Fernández, Daniel Ignacio; Gómez-Miguel, Begoña; Solas, M. Teresa; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Arahuetes, Rosa Mª | Fecha de publicación: | 15-sep-2016 | Editor: | Public Library of Science | Citación: | PLoS ONE 11(9): e0162723 (2016) | Resumen: | Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron degenerative disease that has no effective treatment up to date. Drug discovery tasks have been hampered due to the lack of knowledge in its molecular etiology together with the limited animal models for research. Recently, a motor neuron disease animal model has been developed using β-Nmethylamino-L-alanine (L-BMAA), a neurotoxic amino acid related to the appearing of ALS.In the present work, the neuroprotective role of VP2.51, a small heterocyclic GSK-3 inhibitor,is analysed in this novel murine model together with the analysis of autophagy. VP2.51daily administration for two weeks, starting the first day after L-BMAA treatment, leads to total recovery of neurological symptoms and prevents the activation of autophagic processes in rats. These results show that the L-BMAAmurine model can be used to test the efficacy of new drugs. In addition, the results confirmthe therapeutic potential of GSK-3 inhibitors, and specially VP2.51, for the disease-modifying future treatment of motor neuron disorders like ALS. | Descripción: | 16 p.-4 fig. | Versión del editor: | http://dx.doi.org/10.1371/journal.pone.0162723 | URI: | http://hdl.handle.net/10261/146719 | DOI: | 10.1371/journal.pone.0162723 | E-ISSN: | 1932-6203 |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
de Munck_journal.pone_2016.pdf | Artículo principal | 1,65 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
6
checked on 17-abr-2024
SCOPUSTM
Citations
11
checked on 17-abr-2024
WEB OF SCIENCETM
Citations
9
checked on 23-feb-2024
Page view(s)
322
checked on 19-abr-2024
Download(s)
215
checked on 19-abr-2024